Shares of Bristol Myers Squibb Co. BMY rallied 1.86% to $50.94 Tuesday, on what proved to be an all-around favorable trading ...
BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) today and set a price target ...
The hits just keep on coming for Bristol Myers Squibb staffers amid the company's cost-savings program. | Bristol Myers ...
In the assessment of 12-month price targets, analysts unveil insights for Bristol-Myers Squibb, presenting an average target ...
The recent ESMO 2024 data highlighted significant advancements in immunotherapy. Check out the results from Merck, BMY, ...
Zacks.com on MSN7d
Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key FactsThe latest trading session saw Bristol Myers Squibb (BMY) ending at $49.49, denoting a -1% adjustment from its last day's close. This move lagged the S&P 500's daily gain of 0.03%. At the same time, ...
Bristol Myers Squibb Co. has described proteolysis targeting chimera (PROTAC) compounds comprising a E3 ubiquitin ligase-binding moiety coupled to a proto-oncogene tyrosine-protein kinase receptor Ret ...
Guy Gaudreau, a former hockey coach and player, was invited by Flyers coach John Tortorella to help with drills as part of ...
Shares of Bristol Myers Squibb Co. BMY shed 1.00% to $49.49 Tuesday, on what proved to be an all-around mixed trading session ...
Analyst Mohit Bansal from Wells Fargo maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) and keeping the price ...
The Maurice River Historical Society has maintained the East Point lighthouse located at the mouth of the Maurice River on ...
Metastatic solid tumors may be curable now. Among the most profound results presented over the weekend at the European ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback